Merz Pharma: all 172 studies
Page 2 of 2. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- An Open Label Pharmacokinetic Study of Naftin for Tinea CorporisCompletedNCT02466867Phase 4
- Retrospective Evaluation of Combination Treatment With the Ulthera SystemCompletedNCT02444169
- Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines TransducersCompletedNCT02416076Not applicable
- Evaluation of the Safety and Efficacy of the DeScribe™ PatchCompletedNCT02297321Not applicable
- Ultherapy for the Treatment of Spider Veins on the LegsCompletedNCT02286804Not applicable
- Ulthera® System for Treating Axillary HyperhidrosisCompletedNCT02286765Not applicable
- Ultherapy for Buttock LiftCompletedNCT02270892Not applicable
- Pediatric Subjects With Tinea CorporisCompletedNCT02227290Phase 4
- Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral PalsyCompletedNCT02188277Phase 2
- Ultherapy® for the Treatment of Acne ScarsCompletedNCT02145364Not applicable
- Ultherapy® for the Treatment of Erythematotelangiectatic RosaceaCompletedNCT02144181Not applicable
- Peri-orbital and Peri-oral Wrinkle Reduction TrialTerminatedNCT01981252Not applicable
- Effectiveness and Safety Study of Overnight Intensive Patch in ScarsCompletedNCT01910896Not applicable
- A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossCompletedNCT01900041Phase 2
- Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea CrurisCompletedNCT01885156Phase 3
- Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.TerminatedNCT01883414Not applicable
- Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser TreatmentCompletedNCT01810484Not applicable
- Feasibility Study: Ulthera System for the Treatment of RosaceaCompletedNCT01756027Not applicable
- A Study of the Ulthera® System for the Treatment of Axillary HyperhidrosisTerminatedNCT01722461Not applicable
- Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma PatientsCompletedNCT01714960Phase 1
- Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and NeckCompletedNCT01713985Not applicable
- Feasibility Study: Ulthera® System for the Treatment of Axillary HyperhidrosisCompletedNCT01713959Not applicable
- Evaluation of the Ulthera® System for Treatment of the Face and NeckTerminatedNCT01713907Not applicable
- Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary HyperhidrosisCompletedNCT01713673Not applicable
- Feasibility Study: Histological Characterization After Treatment With the Ulthera® SystemTerminatedNCT01713569Not applicable
- Feasibility Study: Lifting and Tightening Neck Skin in PatientsCompletedNCT01708928Not applicable
- Histological Analysis Following Ulthera System Treatment for HyperhidrosisCompletedNCT01708551Not applicable
- Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and NeckCompletedNCT01708512Not applicable
- Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal TissueCompletedNCT01708499Not applicable
- Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ TreatmentsCompletedNCT01708473Not applicable
- Feasibility Study: Ulthera Treatment of the Buttocks and ThighsCompletedNCT01708460Not applicable
- Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ TreatmentCompletedNCT01708447Not applicable
- Feasibility Study: Evaluation of the Ulthera® System for Treatment of the KneesCompletedNCT01708434Not applicable
- Feasibility Study: Lifting and Tightening of the ElbowsCompletedNCT01708382Not applicable
- Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera TreatmentCompletedNCT01708252Not applicable
- Blepharospasm Patient Survey for Patients With BlepharospasmCompletedNCT01686061
- Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial AcneCompletedNCT01591304Not applicable
- Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual SnoringTerminatedNCT01515371Phase 2
- Mederma to Reduce Appearance of Post Surgical ScarsCompletedNCT01504061Not applicable
- Feasibility Study: Evaluation of the Ulthera® System for Treatment of the DécolletéCompletedNCT01485107Not applicable
- Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3CompletedNCT01305187Phase 4
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United StatesCompletedNCT01287247
- Investigation of Memantine in the Treatment of Memory, Concentration or Attention ProblemsCompletedNCT01261741Phase 2
- Contractubex Treatment in Scars After Abdominal Caesarean SectionCompletedNCT01112371Phase 4
- A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male SubjectsCompletedNCT01109680Phase 1
- Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese SubjectsCompletedNCT00983099Phase 1
- Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult SubjectsCompletedNCT00978614Phase 1
- Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification RegimenCompletedNCT00972127Phase 1
- Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective TinnitusCompletedNCT00955799Phase 3
- Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane MesylateCompletedNCT00955760Phase 1
- Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of NeramexaneCompletedNCT00936026Phase 1
- Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female SubjectsCompletedNCT00915174Phase 1
- Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® SoftCompletedNCT00877279Phase 3
- Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective TinnitusTerminatedNCT00827008Phase 3
- Memantine and Validation of a New Alzheimer's Disease ScaleCompletedNCT00804271Phase 3
- Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired NystagmusTerminatedNCT00799942Phase 2
- Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing DisordersWithdrawnNCT00773591Phase 2
- Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective TinnitusCompletedNCT00772980Phase 3
- Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the EyesCompletedNCT00747422Not applicable
- Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective TinnitusCompletedNCT00739635Phase 3
- Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy VolunteersCompletedNCT00712283Phase 1
- Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown LinesCompletedNCT00694148Phase 3
- Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired NystagmusCompletedNCT00661440Phase 2
- Memantine - Communication StudyCompletedNCT00624026Phase 3
- Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical DystoniaCompletedNCT00541905Phase 4
- Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital WrinklesCompletedNCT00541723Phase 3
- Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A ProductsCompletedNCT00515944Phase 1
- Blepharospasm Short IntervalTerminatedNCT00507637Phase 2
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown LinesCompletedNCT00430963Phase 3
- Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown LinesCompletedNCT00430586Phase 2
- Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial FoldsCompletedNCT00429520Phase 4
- Neramexane for TinnitusCompletedNCT00405886Phase 2